Jennifer Felsberg
About Jennifer Felsberg
Jennifer Felsberg is a Market Access and Pricing specialist at Bristol Myers Squibb in München, with a background in health economics, financial advising, and pharmaceutical technology.
Current Role at Bristol Myers Squibb
Jennifer Felsberg currently holds a position in Market Access and Pricing at Bristol Myers Squibb. She has been with the company since May 2021, working in München, Bayern, Deutschland. Her role involves focusing on the strategic aspects of market access, ensuring that pharmaceutical products are accessible and priced appropriately within the healthcare market.
Professional Experience in the Pharmaceutical Industry
Jennifer has substantial experience in the pharmaceutical industry, having worked as a Staatlich geprüfter pharmazeutisch-technischer Assistent at a pharmacy in Berlin und Umgebung, Deutschland, for almost nine years from 2010 to 2019. This role allowed her to gain a solid foundation in pharmaceutical technology, which later supported her transition into market access and pricing roles.
Previous Roles in Finance and Project Management
Before joining Bristol Myers Squibb, Jennifer worked in various capacities. She served as a Finanzberaterin at Postbank Deutschland from 2016 to 2019. She also held a brief tenure as a Projektmanager for two months in 2018 at Inceptua Group in Berlin. These roles provided her with a well-rounded skill set that includes financial advising and project management in the healthcare sector.
Educational Background
Jennifer Felsberg has a solid academic foundation in health care management and related fields. She earned a Master of Science (MS) in Health Care Management from Universität Greifswald, completing her studies from 2018 to 2021. Prior to that, she obtained a Bachelor of Arts in Management Gesundheitswesen from Hochschule Zittau/Görlitz, covering a period from 2015 to 2018.
Expertise in Digital Health Applications (DiGA)
Jennifer has specific expertise in Digital Health Applications (DiGA), which encompasses modern digital tools designed to improve patient care and streamline healthcare processes. Her specialization in health economics and pharmaceutical market access complements her knowledge in digital health, positioning her as a valuable asset in the integration of innovative technologies in healthcare.